Drug utilization patterns and dosing appropriateness of antirheumatic drugs in outpatients with rheumatoid arthritis at Harapan dan Doa General Hospital, Bengkulu City, Indonesia
Abstract
Rheumatoid arthritis (RA) is an autoimmune disease that requires long-term treatment and careful management. Inappropriate therapy may increase morbidity and mortality; therefore, appropriate drug selection and prescribing are essential to improving healthcare quality, particularly in hospital settings. This study aimed to determine the prescribing patterns of medications for patients with rheumatoid arthritis at Harapan dan Doa General Hospital in Bengkulu City. A descriptive, quantitative design was employed, utilizing a total sampling technique. The results showed that, based on drug combination patterns, most patients received triple-drug therapy (46.66%), followed by dual therapy (31.61%) and monotherapy (21.64%). The most common monotherapy was etoricoxib (8.33%), while the most frequent two-drug combination was methotrexate and methylprednisolone (11.66%). The predominant three-drug combination consisted of methotrexate, methylprednisolone, and meloxicam (15%). Based on therapeutic class, the prescribed drugs included nonsteroidal anti-inflammatory drugs (NSAIDs) (80%), corticosteroids (71.66%), disease-modifying antirheumatic drugs (DMARDs) (61.66%), and analgesics (10%). Although all prescribed drugs followed the recommended dosing guidelines, NSAIDs and corticosteroids were used more frequently than methotrexate. This pattern may reflect variations in clinical practice or differences in patient characteristics.
References
Savitri, S. A., Kartidjo, P., Rahmadi, A. R., & Vikasari, S. N. Hubungan Pemilihan Obat dan Keberhasilan Terapi Pasien Rheumatoid Arthritis. Indonesian Journal of Clinical Pharmacy. 2019; 8(4), 237. https://doi.org/10.15416/ijcp.2019.8.4.237
Nata, A. S., Kurniawati, D., Herawati, A., & Melviani, M. Studi Rasionalitas Penggunaan Obat Rheumatoid Arthritis Pada Pasien Rawat Jalan Di Rumah Sakit Umum Daerah Ulin Wilayah Banjarmasin. Jurnal Farmasi SYIFA. 2023;1(2), 59-67. https://doi.org/10.63004/jfs.v1i2.200
WHO. Chronic rheumatic conditions. 2019. https://www.who.int/topics/rheumatic
Riskesdas. Laporan Riskesdas 2018 Nasional.pdf. In Lembaga Penerbit Balitbangkes. 2018; (p.156).
Saputri, E., Hamdiana, & Adriani, L. Hubungan Nyeri Rheumatoid Arthritis Dengan Kemandirian Dalam Aktivitas Kehidupan Sehari-Hari Pada Lansia. Darussalam Indonesian Journal of Nursing and Midwifery. 2022; 4(2), 21-30.
Sofia, J., Nurhasanah, N., & Yanti, S. V. Penatalaksanaan Kompres Hangat Jahe Merah Pada Lansia Dengan Rheumatoid Arthritis: Suatu Studi Kasus. Studi Kasus JIM Fkep. 2022; 1(3), 85-93.
Priyanka P.D., A., Hasanah, N. U., & Alrosyidi, A. F. Studi Pola Penggunaan Obat Antiinflamasi Non Steroid Pada Pasien Rheumatoid Arthritis Di Poli Penyakit Dalam RSUD Dr. H. Slamet Martodirdjo Pamekasan Tahun 2022. Jurnal Ilmiah Farmasi Attamru. 2023; 4(1), 01-14. https://doi.org/10.31102/attamru.2023.4.1.01-14
Pratiwi, A. D. E., Palupi, D. H. S., & Hanifah, H. Z. Profil Penggunaan Imunosupresan Pada Pasien Rheumatoid Arthritis Di Instalasi Rawat Jalan Salah Satu Rumah Sakit Di Kota Semarang. Jurnal Ilmiah Cendekia Eksakta. 2018; 59-64.
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. eds. Pharmacotherapy: A Pathophysiologic Approach, 10e. McGraw-Hill Education;, 2017
Perhimpunan Reumoatologi Indonesia, Penggunaan Obat Anti Inflamasi Non Steroid, 2014
Afridon, A. Faktor-Faktor Yang Berhubungan Dengan Kejadian Rematik Pada Penderita Rematik Di Kelurahan Vi Suku Wilayah Kerja Puskesmas Tanah Garam Kota Solok. Encyclopedia of Education Review. 2021; 2(1), 1-10. https://doi.org/10.33559/eer.v2i1.653
Novianty, F., Kriswiastiny, R., Sani, N., Wiranti, I., & Kumala, I. Faktor Resiko Pasien Rheumatoid Arthritis. Jurnal Penelitian Perawat Profesional. 2024; 6(6), 2355-2366.
Hernawati, D., I, H. R. R., & Rijai, L. Analisis Penggunaan DMARD dan Antiinflamasi Pada Penderita Rheumatoid Arthritis Di RSUD Abdoel Wahab Sjahranie Samarinda. Jurnal Mandala Pharmacon Indonesia (JMPI). 2024; 10(1), 74-79. https://doi.org/10.35311/jmpi.v10i1.498
Meri, & Afrilia, W. S. Rheumatoid Factor (Rf) Pada Lanjut Usia. Jurnal Kesehatan Bakti Tunas Husada: Jurnal Ilmu-Ilmu Keperawatan, Analis Kesehatan Dan Farmasi. 2019; 19(1), 93-99. https://doi.org/10.36465/jkbth.v19i1.454
Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154(3):500-514. https://doi.org/10.1053/j.gastro.2017.10.049
Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022;291(5):557-574. https://doi.org/10.1111/joim.13505
American College of Rheumatology. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021 Jul;73(7):924-939.
Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216-2229. https://doi.org/10.1016/j.clinthera.2017.09.011
Copyright (c) 2025 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.
